Home›Companies›Biotech & Pharma›Aoa Dx

Aoa DX Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 15, 2025·Suggest an edit

About Aoa Dx

Aoa Dx is a private company based in Denver, Colorado. It has reported $38,681,595 raised in five offerings on Form D since July 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 1, 2025Oct 15, 2025$8,085,364of $30.5M target40$202KEquity, OptionsRule 506(b)Form D ↗
Dec 5, 2024Dec 19, 2024$1,845,060of $7.5M target15$123KDebt, OptionsRule 506(b)Form D ↗
Jul 11, 2023Jul 26, 2023$23,611,721of $24.1M target119$198KEquityRule 506(b)Form D ↗
Nov 3, 2021Nov 18, 2021$2,639,450of $5.0M target33$79,983OptionsRule 506(b)Form D ↗
Feb 26, 2021Jul 7, 2021$2,500,000fully sold38$65,789Debt, OptionsRule 506(b)Form D ↗
Total, five offerings$38,681,595

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aoa Dx's Form D filed Oct 15, 2025.

SS
Surbhi Sarna
Director
AJ
Anna Jeter
Executive officer
AM
Abigail Mcelhinny
Executive officer
OZ
Oriana Papin-Zoghbi
President and director
JF
AF
Alexander Fisher
Executive officer

Earlier filings also listed Oriana Zoghbi-Harb (president and director, last listed Nov 2021) and Anna Milik Jeter (executive officer and director, last listed Nov 2021).

Sources

  1. SECAOA DX Inc. filing history